Relative incidence of fever admission and attributable cases (per 100 000 vaccinations) in the 3 days following vaccination with DTaP-IPV-Hib dose preintroduction and postintroduction of pre-4CMenB
| Model and dose | Pre-4CMenB vaccine introduction | Post-4CMenB vaccine introduction | ||||
| No of events | RI (95% CI) | Attributable cases per 100 000 vaccinations (95% CI) | No of events | RI (95% CI) | Attributable cases per 100 000 vaccinations (95% CI) | |
| Dose 1 | 27 | 3.00 (1.99 to 4.53) | 33 (29 to 49) | 95 | 10.78 (8.31 to 14.00) | 162 (129 to 195) |
| Dose 2 | 3 | 0.43 (0.14 to 1.36) | −6 (−44 to 1) | 14 | 2.20 (1.27 to 3.83) | 14 (5 to 25) |
| Dose 3 | 15 | 2.51 (1.47 to 4.27) | 16 (7 to 28) | 50 | 9.80 (7.06 to 13.60) | 84 (62 to 109) |
RI, relative incidence; 4CMenB, 4 component Meningococcal B.